Cargando…

Changed Profile of Serum Transferrin Isoforms in Primary Biliary Cholangitis

Liver damage affects the synthesis of proteins and glycoproteins, and alters their posttranslational modification, such as glycosylation changing the serum profile of glycoprotein isoforms. The retention of hydrophobic bile acids in the course of cholestatic liver diseases is a major cause of liver...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grytczuk, Agnieszka, Bauer, Alicja, Gruszewska, Ewa, Cylwik, Bogdan, Chrostek, Lech
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564153/ https://www.ncbi.nlm.nih.gov/pubmed/32911601 http://dx.doi.org/10.3390/jcm9092894

Ejemplares similares

The Serum Profile of Transferrin Isoforms in Pancreatitis
por: Mucha, Agnieszka, et al.
Publicado: (2022)

Serum profile of transferrin isoforms in juvenile idiopathic arthritis: a preliminary study
por: Gruszewska, Ewa, et al.
Publicado: (2018)

Non-Invasive Indirect Markers of Liver Fibrosis after Interferon-Free Treatment for Hepatitis C
por: Przekop, Dagmara, et al.
Publicado: (2021)

Total and Free Serum Sialic Acid Concentration in Liver Diseases
por: Gruszewska, Ewa, et al.
Publicado: (2014)

Noninvasive Indirect Markers of Liver Fibrosis in Alcoholics
por: Chrostek, Lech, et al.
Publicado: (2019)

Comparison of hyaluronic acid in patients with rheumatoid arthritis, systemic sclerosis and systemic lupus erythematosus
por: Cylwik, Bogdan, et al.
Publicado: (2021)

The effect of the severity of liver cirrhosis on the level of lipids and lipoproteins
por: Chrostek, Lech, et al.
Publicado: (2013)

High serum N-terminal propeptide of procollagen type III concentration is associated with liver diseases
por: Gudowska, Monika, et al.
Publicado: (2017)

Sialic acid level reflects the disturbances of glycosylation and acute-phase reaction in rheumatic diseases
por: Chrostek, Lech, et al.
Publicado: (2013)

Diagnostic Power of Galectin-3 in Rheumatic Diseases
por: Gruszewska, Ewa, et al.
Publicado: (2020)

Simple non-invasive markers for early diagnosis and determination of the severity of liver diseases
por: Gudowska, Monika, et al.
Publicado: (2016)

Hyaluronic acid concentration in liver diseases
por: Gudowska, Monika, et al.
Publicado: (2015)

Concentration of Serum Matrix Metalloproteinase-3 in Patients With Primary Biliary Cholangitis
por: Bauer, Alicja, et al.
Publicado: (2022)

Liver function in COVID-19 infection
por: Przekop, Dagmara, et al.
Publicado: (2021)

Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis
por: Sarcognato, Samantha, et al.
Publicado: (2021)

Detection of Autoantibodies Against Nucleoporin p62 in Sera of Patients With Primary Biliary Cholangitis
por: Bauer, Alicja, et al.
Publicado: (2019)

Osteoporosis in primary biliary cholangitis
por: Danford, Christopher J, et al.
Publicado: (2018)

Baricitinib and primary biliary cholangitis
por: Gordon, Stuart C., et al.
Publicado: (2021)

Changes of Serum IgG Glycosylation Patterns in Primary Biliary Cholangitis Patients
por: Zeng, Xiaoli, et al.
Publicado: (2021)

Overlap Syndrome between Primary Biliary Cholangitis and Primary Sclerosing Cholangitis
por: Sundaram, Sridhar, et al.
Publicado: (2018)

Serum Metabolomics Analysis Reveals a Distinct Metabolic Profile of Patients with Primary Biliary Cholangitis
por: Hao, Juan, et al.
Publicado: (2017)

Evaluation of the United Kingdom‐primary biliary cholangitis and global primary biliary cholangitis group prognostic models for primary biliary cholangitis patients treated with ursodeoxycholic acid in the U.S. population
por: Alomari, Mohammad, et al.
Publicado: (2019)

An Assessment of the Serum Activity of ADH and ALDH in Patients with Primary Biliary Cholangitis
por: Wolszczak-Biedrzycka, Blanka, et al.
Publicado: (2022)

Extrahepatic Manifestations of Primary Biliary Cholangitis
por: Chalifoux, Sara L, et al.
Publicado: (2017)

Obeticholic acid for primary biliary cholangitis
Publicado: (2020)

Current understanding of primary biliary cholangitis
por: Tanaka, Atsushi
Publicado: (2021)

Primary biliary cholangitis: pathogenic mechanisms
por: Prieto, Jesús, et al.
Publicado: (2021)

The Role of Epigenetics in Primary Biliary Cholangitis
por: Gerussi, Alessio, et al.
Publicado: (2022)

Obeticholic Acid for Primary Biliary Cholangitis
por: Floreani, Annarosa, et al.
Publicado: (2022)

Risk Stratification in Primary Biliary Cholangitis
por: Martini, Francesco, et al.
Publicado: (2023)

Predicting Risk in Primary Biliary Cholangitis
por: Cho, Eun Ju
Publicado: (2023)

Follicular T Helper Cell Signatures in Primary Biliary Cholangitis and Primary Sclerosing Cholangitis
por: Adam, Leonie, et al.
Publicado: (2018)

Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: Current Knowledge of Pathogenesis and Therapeutics
por: Park, Ji-Won, et al.
Publicado: (2022)

Gut microbial profile of treatment-naive patients with primary biliary cholangitis
por: Zhou, Yi-jun, et al.
Publicado: (2023)

Analysis of Autoantibodies against Promyelocytic Leukemia Nuclear Body Components and Biochemical Parameters in Sera of Patients with Primary Biliary Cholangitis
por: Bauer, Alicja, et al.
Publicado: (2021)

Overlap syndrome of primary biliary cholangitis and primary sclerosing cholangitis: two case reports
por: Yacoub, Haythem, et al.
Publicado: (2023)

Biomarkers for primary biliary cholangitis: current perspectives
por: Kouroumalis, Elias, et al.
Publicado: (2018)

Genetic Contribution to the Pathogenesis of Primary Biliary Cholangitis
por: Joshita, Satoru, et al.
Publicado: (2017)

New treatments/targets for primary biliary cholangitis
por: Corpechot, Christophe, et al.
Publicado: (2019)

Primary Biliary Cholangitis-associated Palmar Keratosis
por: Usami, Jun
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s9jlit0ndru3i8u791ov1vqqt5